‘United to Stop TB’ is the theme chosen to commemorate the World TB Day in 2017. And, unfortunately, define a need for public health worldwide, tuberculosis is still one of the ten leading causes of death in the world. Although the disease has a high prevalence worldwide, 95% of deaths occur in developing countries development, where access to the diagnostic methods and treatments is more difficult for the population with fewer resources.
Spain is among the countries of the European Union where more cases are detected: 12.7 per day
In fact, Spain, along with Portugal and Greece, is among the countries of the European Union where more cases are detected (12.7 per day), while a reduction of 4.27% in 2014, according to data provided by the National Center of epidemiology of the Instituto de Salud Carlos III has been. The media in our country is 7.54 cases of infection per 100,000 population. 30% of those affected are immigrants, and among the Spaniards, the disease attacks especially to seniors 65 years by having a more weakened immune system, or suffer chronic diseases whose treatment lowered defenses.
One of the objectives of development-sustainable for the World Health Organization (who) is to reduce by 90% the incidence of tuberculosis in the world by 2035; However, Masoud Dara, program coordinator of communicable diseases, joint Tuberculosis, HIV and Hepatitis in the European region of this organization, just warn that it will not be possible to achieve this, because there are no sufficient resources to prevent and adequately treat this infectious disease, which took the lives of 1.8 million people only in 2015.
Multidrug-resistant TB and co-infection with HIV, the major challenges
It is estimated that one-third of human beings is infected with tuberculosis, but 99% of those affected is unknown it, and only about 10% will develop the disease. Develop strategies that allow early detection is key to reducing its incidence, but what most worries experts are cases of MDR-TB drugs and co-infection with HIV, which affects 9% of the patients at this time.
Tuberculosis treatment is prolonged and expensive, and the resistance to antibiotics have further hindered the fight against the spread of this disease. Said Masoud Dara in the framework of the celebration of the 6th day of update of Tuberculosis, so indispensable that Governments finance research of new therapies and facilitate the access of the population to available treatments.
Advances in the fight against tuberculosis
Currently there are several lines of research aiming to prevent to the extent possible tuberculosis and develop new, more effective therapies that will reduce the time that it takes to cure the disease, which currently is in six months – as some vaccines in experimental phase, or the probiotic Nyaditum RESA, which is administered orally and decreases the risk of developing active tuberculosis.
In Spain, the creation of the National Plan for tuberculosis, which has the support of the Ministry of health, social services and equality, and that is expected to get underway at the end of this year, is one of the strategies which aims to improve the prevention and treatment of this disease.
Also at the end of 2017, in November, will take place in Moscow (Russia) the World Conference of Ministers on Elimination of Tuberculosis, in which will address is the need to develop global strategies to respond globally against antimicrobial resistance, in the context of the objectives of sustainable development.